{"id":"CHEMBL1088324","canonicalSmiles":"O=C(O)CCP(=O)(O)O","inchiKey":"NLBSQHGCGGFVJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1088324","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03379"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL117785","canonicalSmiles":"COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2","inchiKey":"MKJIEFSOBYUXJB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TETRABENAZINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nitoman","Revocon","Tetmodis","Tetrabenazine","Xenazine","Xenazine 25"],"synonyms":["NSC-169886","RO 1-9569","RO-1-9569","RO-19569","Tetrabenazine"],"crossReferences":{"DailyMed":["deutetrabenazine","tetrabenazine"],"PubChem":["144205356","170464675","29216102","50086515","90341774"],"Wikipedia":["Tetrabenazine"],"drugbank":["DB04844"],"chEBI":["64028"]},"childChemblIds":["CHEMBL3137326"],"linkedTargets":{"rows":["ENSG00000165646"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0004280","MONDO_0003441","EFO_0004895","EFO_1000632","EFO_0004152","EFO_0003843"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for huntington disease and chorea and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1185001","canonicalSmiles":"CNC(=O)[C@@H]1Cc2ccc(NS(=O)(=O)O)cc2CN1C(=O)OCc1ccccc1","inchiKey":"MFDBNNQUDZFSES-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1185001","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08549"]},"childChemblIds":["CHEMBL383033"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL119604","canonicalSmiles":"OCCNCCO","inchiKey":"ZBCBWPMODOFKDW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHANOLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dabco deoa-lf","Diethanolamine","Diolamine","N,n'-iminodiethanol","NSC-4959","Niax deoa-lf","Tegoamin deoa 85"],"crossReferences":{"PubChem":["144208899","144210354","17389594","49679190"],"Wikipedia":["Diethanolamine"],"chEBI":["28123"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1200392","canonicalSmiles":"CN(C)CCOC(C)(c1ccccc1)c1ccccn1.O=C(O)CCC(=O)O","inchiKey":"KBAUFVUYFNWQFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOXYLAMINE SUCCINATE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1004","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decapryn","Doxy-sleep-aid","Doxylamine succinate","Unisom"],"synonyms":["Alsodorm","Donormil","Donormyl","Dormidina","Doxylamine hydrogen succinate","Doxylamine succinate","Gittalun","Hoggar n","Meraprina","NSC-74772"],"crossReferences":{"DailyMed":["doxylamine%20succinate"],"PubChem":["144207064","144209276","144213178","170465171","26747491","50106112","56423151","855569"],"chEBI":["82461"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000544","HP_0002017"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and has 3 investigational indications."}
{"id":"CHEMBL1200477","canonicalSmiles":"O=c1[n-]cnc2[nH]ncc12.[Na+]","inchiKey":"PTJRZVJXXNYNLN-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ALLOPURINOL SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1467","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Allopurinol sodium","Aloprim"],"synonyms":["Allopurinol sodium","Allopurinol sodium salt","NSC-108836"],"crossReferences":{"DailyMed":["allopurinol%20sodium"]},"linkedTargets":{"rows":["ENSG00000158125"],"count":1},"linkedDiseases":{"rows":["EFO_1001793"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996 and has 1 investigational indication."}
{"id":"CHEMBL1200521","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12.O=C(O)CC(O)C(=O)O","inchiKey":"QHATUKWEVNMHRY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMOTRIPTAN MALATE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1505","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Almotriptan malate","Axert"],"synonyms":["Almogran","Almotriptan d,l-hydrogenmalate","Almotriptan malate","Almotriptan maleate","LAS 31416 D,L-MALATE ACID","LAS-31416","LAS-31416 D,L-MALATE ACID","LAS-31416-D,L-MALATE-ACID","PNU-180638E"],"crossReferences":{"DailyMed":["almotriptan%20malate"],"chEBI":["53781"]},"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546","ENSG00000179097"],"count":3},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and is indicated for migraine disorder."}
{"id":"CHEMBL1200755","canonicalSmiles":"CCNCC.CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(OS(=O)(=O)O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCC(=O)N1)[C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O","inchiKey":"FHDKSYKZXIFRKJ-CBCFNHQSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CERULETIDE DIETHYLAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201355","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tymtran"],"synonyms":["Caerulein diethylamine","Ceosunin","Ceruletide diethylamine","Ceruletide diethylamine salt","Takus"],"crossReferences":{"chEBI":["59223"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200970","canonicalSmiles":"CCN(CC)C(C)CN1c2ccccc2Sc2ccccc21.Cl","inchiKey":"VXPCQISYVPFYRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHOPROPAZINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1206","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsidol"],"synonyms":["Ethopropazine hcl","Ethopropazine hydrochloride","NSC-169467","NSC-64074","Profenamine","Profenamine hibenzate","Profenamine hydrochloride","Prophenamine hydrochloride"],"crossReferences":{"PubChem":["144204047","170465065","26748043","26748044"],"chEBI":["31568"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201213","canonicalSmiles":"CCC(NC(C)C)C(O)c1ccc(O)c(O)c1","inchiKey":"HUYWAWARQUIQLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOETHARINE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dilabron","Etyprenaline","Isoetarine","Isoetharine","Neoisuprel","WIN 3406","WIN-3046","WIN-3406","WIN3406"],"crossReferences":{"PubChem":["90341304"],"Wikipedia":["Isoetarine"],"drugbank":["DB00221"],"chEBI":["6005"]},"childChemblIds":["CHEMBL1200920","CHEMBL1201153"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for airway obstruction."}
{"id":"CHEMBL1201232","canonicalSmiles":"CC(C)[N+](C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)C(C)C","inchiKey":"JTPUMZTWMWIVPA-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROPAMIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Isopropamide","Isopropamide cation","Isopropamide ion"],"crossReferences":{"PubChem":["11112197","144203913","170465291"],"Wikipedia":["Isopropamide"],"drugbank":["DB01625"],"chEBI":["6043"]},"childChemblIds":["CHEMBL1200347"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201288","canonicalSmiles":"O=C1CN(/N=C/c2ccc(-c3ccc([N+](=O)[O-])cc3)o2)C(=O)N1","inchiKey":"OZOMQRBLCMDCEG-VIZOYTHASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DANTROLENE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["2-methylbenzoic acid anilide","BAS-305","BAS-3050","BAS-3050F","Bebenil","Dantrolene","F-368","Mebenil","NSC-227402","NSC-26404","O-methylbenzanilide","O-toluanilide","SHA-458100"],"crossReferences":{"DailyMed":["dantrolene%20sodium"],"PubChem":["26756482","26756773"],"TG-GATEs":["119"],"Wikipedia":["Dantrolene"],"drugbank":["DB01219"]},"childChemblIds":["CHEMBL2067986","CHEMBL928"],"linkedTargets":{"rows":["ENSG00000198838","ENSG00000196218"],"count":2},"linkedDiseases":{"rows":["EFO_1001340","EFO_0000546","HP_0001257","MONDO_0005301","EFO_0020003","EFO_0005306","EFO_0000712","HP_0001945","EFO_1001919","EFO_1000632","Orphanet_3463"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 6 approved and 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201444","drugType":"Small molecule","blackBoxWarning":false,"name":"CRYPTENAMINE ACETATES","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Unitensen"],"synonyms":["Cryptenamine acetates"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201560","drugType":"Protein","blackBoxWarning":true,"name":"PEGINTERFERON ALFA-2A","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pegasys","Roferon-A"],"synonyms":["Peg-interferon alfa 2a","Peg-interferon alfa-2a","Peginterferon .alpha.-2a","Peginterferon alfa-2a","Peginterferon-alfa-2a","Pegyinterferon-alfa-2a","Pegylated interferon alfa-2a","Pegylated interferon alpha 2a","Pegylated-interferon alfa 2a","Pegylated-interferon-alfa-2a","RO 25-8310/000","RO-258310000"],"crossReferences":{"DailyMed":["peginterferon%20alfa-2a"],"DrugCentral":["5158"],"Wikipedia":["Peginterferon_alfa-2a"]},"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0000756","MONDO_0007254","MONDO_0021063","MONDO_0002087","EFO_0008496","EFO_0007304","EFO_0000565","EFO_0002430","MONDO_0002050","EFO_0000339","EFO_0000544","EFO_0000182","EFO_1000251","EFO_0004272","EFO_0003047","EFO_0000479","HP_0012115","EFO_0000616","MONDO_0008170","EFO_0000222","EFO_0004197","HP_0001873","EFO_0002429","EFO_0004239","EFO_0000311","EFO_1000026","EFO_0001422","EFO_0009260","EFO_0004220","EFO_0000095","EFO_0000764","MONDO_0002367","EFO_0001378","MONDO_0024880"],"count":35},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 approved and 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201650","drugType":"Unknown","blackBoxWarning":false,"name":"THYROGLOBULIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Proloid","Thyroglobulin"],"synonyms":["Thyroglobulin"],"description":"Unknown drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL1213529","canonicalSmiles":"C=CC(=O)O","inchiKey":"NIXOWILDQLNWCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACRYLIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acrylic Acid"],"crossReferences":{"PubChem":["144205925","29218004"],"Wikipedia":["Acrylic_acid"],"drugbank":["DB02579"],"chEBI":["18308"]},"childChemblIds":["CHEMBL3184669","CHEMBL3185326"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229780","canonicalSmiles":"COC(=O)c1ccccc1S(=O)(=O)NC(=O)N(C)c1nc(C)nc(OC)n1","inchiKey":"VLCQZHSMCYCDJL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBENURON METHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tribenuron Methyl"],"crossReferences":{"PubChem":["144209747","26757182"],"drugbank":["DB03656"],"chEBI":["9678"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231683","canonicalSmiles":"CC(C)Nc1ccc2cnn(-c3cncc(-n4ccc(CC(=O)O)c4)n3)c2c1","inchiKey":"BBYRUZKRFAIQSR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231683","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07546"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232817","canonicalSmiles":"O=CN1CCCCC1","inchiKey":"FEWLNYSYJNLUOO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212424"],"drugbank":["DB04113"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233278","canonicalSmiles":"OCCSSCCO","inchiKey":"KYNFOMQIXZUKRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233278","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212498"],"drugbank":["DB02486"],"chEBI":["43136"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237210","canonicalSmiles":"CC(C)=CCC[C@]1(C)[C@@H](CC=C(C)C)C[C@]2(CC=C(C)C)C(=O)C(CC=C(C)C)=C(O)[C@@]1(C(=O)C(C)C)C2=O","inchiKey":"IWBJJCOKGLUQIZ-HQKKAZOISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1237210","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Hyperforin"],"drugbank":["DB01892"],"chEBI":["5834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1241348","canonicalSmiles":"C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O","inchiKey":"LLGDPTDZOVKFDU-XUHJSTDZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FALDAPREVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 201335","BI-201335","BI201335","Faldaprevir"],"crossReferences":{"drugbank":["DB11808"]},"childChemblIds":["CHEMBL3544915"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1279","canonicalSmiles":"CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1","inchiKey":"XPSQPHWEGNHMSK-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FROVATRIPTAN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Migard","Mylatrip"],"synonyms":["Allergo filmtabletten","Frova","Frovatriptan"],"crossReferences":{"DailyMed":["frovatriptan%20succinate"],"Wikipedia":["Frovatriptan"],"drugbank":["DB00998"]},"childChemblIds":["CHEMBL1200371","CHEMBL2138684"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546"],"count":2},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for migraine disorder and has 1 investigational indication."}
{"id":"CHEMBL130266","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"XCCTYIAWTASOJW-XVFCMESISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URIDINE_DIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UDP","Uridine 5'-Diphosphate","Uridine Diphosphate","Uridine-5'-Diphosphate"],"crossReferences":{"PubChem":["90341062"],"Wikipedia":["Uridine_diphosphate"],"drugbank":["DB03435"],"chEBI":["17659"]},"childChemblIds":["CHEMBL1457622","CHEMBL4295086","CHEMBL1096401"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1316726","canonicalSmiles":"O=C(O)/C=C\\c1c[nH]cn1","inchiKey":"LOIYMIARKYCTBW-UPHRSURJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIS-UROCANIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cis-urocanic acid","Imidazole-4-acrylic acid, (z)-","NSC-407934","Urocanic acid, cis-"],"crossReferences":{"PubChem":["11111951"],"chEBI":["30818"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL132530","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@@]43C)[C@@H]1CCC2=O","inchiKey":"OSVMTWJCGUFAOD-KZQROQTASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMESTANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lentaron"],"synonyms":["4-oh-androstene-3,17-dione","CGP 32349","CGP-32349","Formestane","NSC-282175"],"crossReferences":{"PubChem":["11532941","143659","144205664","144207058","144212603","170466203","26757799","56463214"],"Wikipedia":["Formestane"],"drugbank":["DB08905"],"chEBI":["75172"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for neoplasm."}
{"id":"CHEMBL1328898","canonicalSmiles":"COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1","inchiKey":"XBBDACCLCFWBSI-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELEVODOPA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHF-1301","Levomet","Melevodopa"],"crossReferences":{"PubChem":["11111051","50111022","90341190"],"drugbank":["DB13313"]},"childChemblIds":["CHEMBL1255756"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1351","drugType":"Small molecule","blackBoxWarning":true,"name":"CARBOPLATIN","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Carboplatin","Paraplatin"],"synonyms":["Carboplatin","Carboplatine","Carboplatinum","JM-8","NSC-201345","NSC-241240","Paraplatin"],"crossReferences":{"DailyMed":["carboplatin"],"DrugCentral":["4133"],"PubChem":["26748613","26748614","26748615","50110983"],"TG-GATEs":["133"],"chEBI":["31355"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 6 approved and 166 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL136478","drugType":"Small molecule","blackBoxWarning":true,"name":"SODIUM NITROPRUSSIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2097081","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nipride","Nitropress","Sodium nitroprusside"],"synonyms":["NSC-755844","Nipruss","Nitroprusside sodium","Sodium nitroferricyanide","Sodium nitroprusside","Sodium nitroprusside anhydrous","Sodium nitroprusside dihydrate","Sodium nitroprusside hydrate"],"crossReferences":{"DailyMed":["sodium%20nitroprusside"],"Wikipedia":["Sodium_nitroprusside"],"chEBI":["29321"]},"linkedTargets":{"rows":["ENSG00000061918","ENSG00000123201"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0000373","EFO_0000319","EFO_0001358","EFO_0001073","EFO_0000537","EFO_1000653","MP_0001914","MP_0001845","GO_0007568","EFO_0004517","EFO_0008585","EFO_0003144","EFO_0004272"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and is indicated for congestive heart failure and hemorrhage and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1407943","canonicalSmiles":"Clc1ccc(Cn2c(CN3CCCC3)nc3ccccc32)cc1","inchiKey":"CJXAEXPPLWQRFR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLEMIZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL 20 [AS HYDROCHLORIDE]","AL-20 FREE BASE","Clemizole","Clemizole hydrochloride","NSC-46261"],"crossReferences":{"PubChem":["11110952","11110953","90341639"],"Wikipedia":["Clemizole"],"chEBI":["52140"]},"childChemblIds":["CHEMBL3216363","CHEMBL1256817"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL148333","canonicalSmiles":"CNCCNS(=O)(=O)c1cccc2cnccc12","inchiKey":"PJWUXKNZVMEPPH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL148333","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111503","124880801","26755703"],"drugbank":["DB07997"],"chEBI":["43561"]},"childChemblIds":["CHEMBL1395058"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL151649","canonicalSmiles":"S=C=NCCc1ccccc1","inchiKey":"IZJDOKYDEWTZSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENETHYLISOTHIOCYANATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenethyl Isothiocyanate","Phenethylisothiocyanate","Phenylethyl Isothiocyanate"],"crossReferences":{"PubChem":["124400","144207298"],"Wikipedia":["Phenethyl_isothiocyanate"],"drugbank":["DB12695"],"chEBI":["351346"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1539","canonicalSmiles":"COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC","inchiKey":"PJSFRIWCGOHTNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADOXINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fanasil","Fanzil","Sulforthamidine","Sulphormethoxine"],"synonyms":["Fanasulf","J21.373J","NSC-759319","RO 4-4393","RO-4-4393","RO-44393","Sulfadoxin","Sulfadoxine","Sulfadoxinum","Sulphadoxine","WR-4073"],"crossReferences":{"PubChem":["11112518","144204074","170464751","56463175"],"Wikipedia":["Sulfadoxine"],"drugbank":["DB01299"],"chEBI":["9329"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 8 investigational indications."}
{"id":"CHEMBL1626223","canonicalSmiles":"CN1CCCN=C1/C=C/c1cccs1","inchiKey":"YSAUAVHXTIETRK-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRANTEL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Konvermex","Pyrantel"],"crossReferences":{"drugbank":["DB11156"],"chEBI":["8654"]},"childChemblIds":["CHEMBL2105309","CHEMBL1585303","CHEMBL1599768"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for helminthiasis."}
{"id":"CHEMBL1651998","canonicalSmiles":"CC1(O)CCC(C(C)(C)O)CC1","inchiKey":"RBNWAMSGVWEHFP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERPIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cis-1,8-p-menthanediol","Cis-p-menthan-1,8-diol","NSC-403856","Terpin"],"crossReferences":{"PubChem":["144205199","474118"],"Wikipedia":["Terpin_hydrate"]},"childChemblIds":["CHEMBL2105614"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1705373","canonicalSmiles":"COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1C(NC(C)=O)CC2","inchiKey":"LEQAKWQJCITZNK-MSQQGMGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOCOLCHICOSIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Coltramyl","Coltrax","Miorel","Musco-ril","NSC-147755","Thiocolchicine 2-glucoside analog","Thiocolchicine glycoside","Thiocolchicoside"],"crossReferences":{"PubChem":["56463708"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1743078","drugType":"Antibody","blackBoxWarning":false,"name":"TEPLIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HOKT3-GAMMA-1 (ALA-ALA)","HUMANIZED OKT3","Humanzied OKT3","MGA-031","MGA031","Teplizumab","hOKT3 gamma 1 (Ala-Ala)"],"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","EFO_0000676","EFO_0002546"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL192154","canonicalSmiles":"N#Cc1cc(-c2ccc(O)c(F)c2)cc2ccc(O)cc12","inchiKey":"NSSOSHDCWCMNDM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL192154","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL193","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]","inchiKey":"HYIMSNHJOBLJNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFEDIPINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adalat","Adalat a.r.","Adalat cc","Adalat ic","Adalat la 20","Adalat la 30","Adalat la 60","Adalat ret","Adalate lp","Adanif xl","Adipine mr 10","Adipine mr 20","Adipine xl","Afeditab cr","Angiopine 10","Angiopine 40 la","Angiopine 5","Angiopine mr 10","Angiopine mr 20","Calanif","Calchan mr 10","Calchan mr 20","Calcilat","Cardilate mr","Coracten sr","Coracten xl","Coroday mr","Fortipine la40","Genalat 10 ret","Genalat 20 ret","Hypolar ret 10","Hypolar ret 20","Hypolar xl 30","Kentipine","Kentipine mr 10","Kentipine mr 20","Neozipine xl","Nife-wolff","Nifedipine","Nifedipress mr 10","Nifedipress mr 20","Nifedotard 20 mr","Nifelease","Nifensar xl","Nifopress mr","Nifopress ret","Nimodrel mr 10","Nimodrel mr 20","Nimodrel xl","Nivaten ret","Procardia","Procardia xl","Slofedipine xl 30","Slofedipine xl 60","Tensipine mr 10","Tensipine mr 20","Unipine xl","Valni 20 ret","Valni xl","Vasad"],"synonyms":["BAY A 1040","BAY-A-1040","Coracten","NSC-757242","Nifedipine","Nifedipine hydrochloride","Nifedipine slow release","Nifedipinum"],"crossReferences":{"DailyMed":["nifedipine"],"PubChem":["104171202","11111548","11111549","11113899","124880908","124880909","124880910","124880913","144203763","144207502","170465006","17388858","26747150","26747151","26752059","26752060","50100293","50104712","50104713","50104714","85231157","90341123"],"TG-GATEs":["91"],"Wikipedia":["Nifedipine"],"drugbank":["DB01115"],"chEBI":["7565"]},"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0007442","MONDO_0005149","EFO_0009660","EFO_0000275","HP_0000093","EFO_0000401","EFO_0000319","EFO_1000782","EFO_1001145","EFO_0000537","Orphanet_418","HP_0012390","MONDO_0012511","EFO_0003890","MONDO_0001134","EFO_1001375","EFO_0004263","EFO_0004253","EFO_0003884","EFO_0003917","EFO_0004225","MONDO_0001641","EFO_0000668"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 14 investigational indications."}
{"id":"CHEMBL197084","canonicalSmiles":"C[C@@]1(C(=O)N[C@@H](CCC(=O)O)C(=O)O)CCCN1C(=O)CN","inchiKey":"BUSXWGRAOZQTEY-SDBXPKJASA-N","drugType":"Protein","blackBoxWarning":false,"name":"TROFINETIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trofinetide"],"crossReferences":{"drugbank":["DB06045"]},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1989587","canonicalSmiles":"CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3CC(C=O)=C4C=C(OCCCl)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C","inchiKey":"QNXUUBBKHBYRFW-QWAPGEGQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FORMOCORTAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Deflamene","Fluderma"],"synonyms":["Formocortal","NSC-150527"],"crossReferences":{"PubChem":["301208"],"drugbank":["DB13664"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2021430","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"PLCQGRYPOISRTQ-FCJDYXGNSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXAMETHASONE SODIUM PHOSPHATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201302","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Decadron","Dexacen-4","Dexacort","Dexair","Dexamethasone","Dexamethasone sodium phosphate","Dexamethasone sodium phosphate preservative free","Hexadrol","Maxidex"],"synonyms":["Dexamethasone 21-phosphate disodium salt","Dexamethasone sodium phosphate","NSC-756722","TLC-399","TLC399","Tlc399"],"crossReferences":{"DailyMed":["dexamethasone%20sodium%20phosphate"],"PubChem":["144206732","144212903"],"chEBI":["4462"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0005539","EFO_1000845","EFO_0010822","MONDO_0017634","HP_0000559","EFO_0004274","MONDO_0002959","EFO_0005558","EFO_0005773","EFO_0008997","EFO_0000565","EFO_0007160","EFO_0009456","EFO_0007520","EFO_0002690","EFO_0004255","EFO_0000676","EFO_0009552","EFO_0004276","EFO_1001250","EFO_0004719","HP_0003072","EFO_0005854","EFO_0009449","EFO_0001642","EFO_1000039","HP_0001742","EFO_0000384","HP_0001873","EFO_1001119","EFO_1002022","MP_0001845","MONDO_0100096","HP_0003040","EFO_1000049","Orphanet_90794","MONDO_0002406","EFO_0000574","MONDO_0004979","EFO_1001051","EFO_0007328","HP_0012424","EFO_0001378","EFO_1001222","EFO_0009491","EFO_1001896","EFO_0007405","MONDO_0003005","EFO_1001205","EFO_1000997","EFO_0005319","EFO_1000764","EFO_1001435","MONDO_0001280","HP_0001094","EFO_0003778","EFO_1000684","EFO_0009509","EFO_0000274","HP_0001915","HP_0004398","EFO_1000694","EFO_0005752","EFO_0007490","EFO_0009609","Orphanet_797","EFO_0000694","EFO_0000685","MONDO_0015128","EFO_0003898","EFO_0000556","EFO_0003929","EFO_0001358","EFO_0003894","EFO_0003843","EFO_1000941","EFO_0002609","EFO_0000311","EFO_0006738","EFO_0003106","EFO_0007257","EFO_0007403","EFO_1001194","EFO_0007141","MONDO_0005178","EFO_0003956","EFO_0004265"],"count":88},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1959 and has 68 approved and 9 investigational indications."}
{"id":"CHEMBL207413","canonicalSmiles":"CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2C(=O)C=C2[C@@H]4C[C@@](C)(C(=O)O)CC[C@]4(C)CC[C@]23C)C1(C)C","inchiKey":"FTQDJVZNPJRVPG-XWEVEMRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOXOLONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetoxolone","Acetylglycyrrhetic acid","Acetylglycyrrhetinic acid","DGS 0110A","DGS-0110A","Glycyrrhetic acid acetate","Glycyrrhetinic acid acetate","Glycyrrhetinyl acetate","NSC-35349","Uralenic acid, acetate"],"crossReferences":{"Wikipedia":["Acetoxolone"],"drugbank":["DB13640"],"chEBI":["81306"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL208239","canonicalSmiles":"CS(=O)(=O)c1ccc(CN2CCN(c3cn[nH]c3-c3cc(Cl)c(O)cc3O)CC2)cc1","inchiKey":"BDFJIEMVNDLSTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL208239","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06957"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096648","canonicalSmiles":"N[13C](N)=O","inchiKey":"XSQUKJJJFZCRTK-OUBTZVSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UREA C 13","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL985","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Breathtek ubt for h-pylori","Helicosol","Meretek ubt kit (w/ pranactin)","Pylori-chek breath test"],"synonyms":["(13c) urea","13-c urea","13-c-urea","13c-urea","Carbon-13 urea","Carbone (13) urea","Urea ((sup 13)c)","Urea (13c)","Urea 13 c","Urea c 13","Urea c-13","Urea, c-13"],"crossReferences":{"drugbank":["DB09510"],"chEBI":["32285"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996."}
{"id":"CHEMBL2103735","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O.CC(=O)O","inchiKey":"KFEFLCOCAHJBEA-ANRVCLKPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CETRORELIX ACETATE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200490","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cetrotide"],"synonyms":["Cetrorelix","Cetrorelix acetate","Cetrotide acetate","D-20761","NS-75A","SB-075 ACETATE"],"crossReferences":{"chEBI":["31387"]},"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000545","EFO_0000731","HP_0000138","EFO_0000660"],"count":4},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 2 investigational indications."}
{"id":"CHEMBL2103743","canonicalSmiles":"C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"SYIKUFDOYJFGBQ-YLAFAASESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TOFACITINIB CITRATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL221959","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xeljanz","Xeljanz xr"],"synonyms":["CP-690,550-10","CP-690550-10","Cp-690550 citrate","Tasocitinib citrate","Tasocitinib monocitrate","Tofacitinib citrate","Tofacitinib monocitrate"],"crossReferences":{"DailyMed":["tofacitinib%20citrate"],"chEBI":["71197"]},"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434","ENSG00000105639","ENSG00000105397"],"count":4},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002690","EFO_0003778","MONDO_0019558"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for rheumatoid arthritis and psoriatic arthritis and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103855","canonicalSmiles":"Cc1ccn(-c2cc(Cl)ccc2[C@@H](Oc2cc(-c3ccc(C[C@H](N)C(=O)O)cc3)nc(N)n2)C(F)(F)F)n1","inchiKey":"NCLGDOBQAWBXRA-PGRDOPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELOTRISTAT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LP 778902","LP-778902","Telotristat"],"crossReferences":{"drugbank":["DB14218"]},"childChemblIds":["CHEMBL4796268"],"linkedTargets":{"rows":["ENSG00000139287","ENSG00000129167"],"count":2},"linkedDiseases":{"rows":["EFO_0000729","EFO_0003086","EFO_1001901","EFO_0001421","EFO_1000852"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2104986","canonicalSmiles":"Cc1ccc(Sc2ccccc2C2CCNCC2)cc1","inchiKey":"CVASBKDYSQKLSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDATIOXETINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LU AA24530","LU-AA24530","Lu aa24530","Tedatioxetine"],"crossReferences":{"drugbank":["DB12641"]},"childChemblIds":["CHEMBL2107377"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000149305","ENSG00000102468","ENSG00000186090","ENSG00000142319","ENSG00000178084","ENSG00000186038","ENSG00000120907","ENSG00000166736","ENSG00000147246"],"count":11},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2105080","canonicalSmiles":"COCc1c(C(=O)OC(C)C)ncc2[nH]c3cccc(Oc4ccc(Cl)cc4)c3c12","inchiKey":"SLYDYLLJUXFULK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEDOCARNIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gedocarnil"],"crossReferences":{"drugbank":["DB13534"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105206","canonicalSmiles":"c1ccc(-c2cc(CCC3CCNCC3)c3ccccc3n2)cc1","inchiKey":"AMEWZCMTSIONOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPEQUALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PK-8165","Pipequaline"],"crossReferences":{"drugbank":["DB13991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105616","canonicalSmiles":"CC(=O)N[C@@H](CC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O","inchiKey":"GUCKKCMJTSNWCU-BQBZGAKWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPAGLUMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-758468","Spaglumic acid"],"crossReferences":{"PubChem":["144204096"],"drugbank":["DB08835"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105728","canonicalSmiles":"CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1","inchiKey":"DYNHJHQFHQTFTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CRENOLANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARO 002","ARO-002","CP 868596","CP-868,596","CP-868596","Crenolanib"],"crossReferences":{"drugbank":["DB11832"]},"childChemblIds":["CHEMBL2146086"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000113721","ENSG00000122025"],"count":3},"linkedDiseases":{"rows":["EFO_1000026","EFO_0000616","EFO_0000503","Orphanet_44890","EFO_0000326","EFO_0000222","EFO_0000519"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2105754","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O.O=C(O)CCC(=O)O","inchiKey":"OGCNTTUPLQTBJI-XFULWGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRELAGLIPTIN SUCCINATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1650443","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SYR-111472 SUCCINATE","SYR-472","SYR111472 SUCCINATE","Trelagliptin succinate","Zafatek"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106851","canonicalSmiles":"CN1CC[C@]23c4c5ccc(OC(=O)c6cccnc6)c4O[C@H]2[C@@H](OC(=O)c2cccnc2)C=C[C@H]3[C@H]1C5","inchiKey":"HNDXBGYRMHRUFN-CIVUWBIHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOMORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,6-dinicotinoylmorphine","Dea no. 9312","IDS-NN-003","Morphine dinicotinate","Morphine dinicotinate (ester)","Morphine dinicotinate ester","Nicomorphine"],"crossReferences":{"drugbank":["DB13454"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107312","canonicalSmiles":"CC(C)C(=O)O[C@@H](OC(=O)NC[C@H](CC(=O)O)c1ccc(Cl)cc1)C(C)C","inchiKey":"JXTAALBWJQJLGN-KSSFIOAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARBACLOFEN PLACARBIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Arbaclofen placarbil","XP-19986","XP19986"],"crossReferences":{"drugbank":["DB08892"]},"linkedTargets":{"rows":["ENSG00000136928","ENSG00000204681"],"count":2},"linkedDiseases":{"rows":["EFO_0003948","HP_0001257","MONDO_0005301","HP_0003418","MONDO_0007079"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2107855","drugType":"Protein","blackBoxWarning":false,"name":"DENENICOKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-982470","Denenicokin","Human interleukin-21","IL-21","IL-21 RECOMBINANT","Il21, human","Interleukin-21","RECOMBINANT HUMAN INTERLEUKIN 21","RIL-21","RIL-21; RECOMBINANT HUMAN INTERLEUKIN 21"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2107866","drugType":"Protein","blackBoxWarning":false,"name":"PEGINESATIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Hematide"],"synonyms":["AF-37702","AF37702","Peginesatide"],"crossReferences":{"DrugCentral":["4234"]},"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0004272"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108060","drugType":"Unknown","blackBoxWarning":false,"name":"VITESPEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Oncophage"],"synonyms":["HSPPC-96","Vitespen"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2108072","drugType":"Enzyme","blackBoxWarning":false,"name":"PAMITEPLASE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pamiteplase","Solinase"],"description":"Enzyme drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108735","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"DRISAPERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Drisapersen","GSK-2402968","GSK-2402968A","GSK2402968","GSK2402968A","Gsk 2402968a","H51AON23","PRO-051","PRO051"],"linkedTargets":{"rows":["ENSG00000198947"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","Orphanet_98473"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109250","drugType":"Antibody","blackBoxWarning":false,"name":"TGN-1412","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CD28-SUPERMAB","TAB-08","TGN-1412","Tab08","Tgn-1412","Tgn1412","Theralizumab"],"linkedTargets":{"rows":["ENSG00000178562"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000685","EFO_1001494","EFO_0002690"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109348","drugType":"Antibody","blackBoxWarning":false,"name":"LFB-R603","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LFB-R603","Lfb-r603"],"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0000095"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109379","drugType":"Antibody","blackBoxWarning":false,"name":"NI-0801","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NI-0801","Ni-0801"],"linkedTargets":{"rows":["ENSG00000169245"],"count":1},"linkedDiseases":{"rows":["EFO_1000668","EFO_1001486"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2111144","canonicalSmiles":"Cc1nn(C)c2c1C(c1ccccc1F)=NCC(=O)N2C","inchiKey":"GDSCFOSHSOWNDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZOLAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Zolazepam"],"crossReferences":{"drugbank":["DB11555"]},"childChemblIds":["CHEMBL2107559"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL222460","canonicalSmiles":"O=c1[nH]c2ccc(C(F)(F)F)cc2c(-c2cc(Cl)ccc2O)c1CCO","inchiKey":"QESHSZWKJULSAR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-223131","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-223131"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL226471","canonicalSmiles":"O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21","inchiKey":"XJJYJNMNYDNXNO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL226471","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["103904965"],"drugbank":["DB07728"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL23","canonicalSmiles":"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1","inchiKey":"HSUGRBWQSSZJOP-RTWAWAEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILTIAZEM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cardizem","Dilt-CD","Diltiazem","Diltiazem extended release","Diltzac","Ditiaz","Surazem","Tiamate","Tiazac"],"crossReferences":{"DailyMed":["diltiazem%20hydrochloride"],"PubChem":["11113366","144204449","170464699","26751609","26751610","50104266","50104267","50104268","50104269","90341257"],"TG-GATEs":["92"],"Wikipedia":["Diltiazem"],"drugbank":["DB00343"],"chEBI":["101278"]},"childChemblIds":["CHEMBL1697","CHEMBL1200805"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0009660","EFO_0000275","EFO_0000538","EFO_1001951","EFO_0003913","HP_0012390","EFO_0003914","EFO_0003911","EFO_1001375","EFO_0003144","EFO_0009552","EFO_0000400","HP_0003124","EFO_0002687","EFO_0001645","EFO_0000701","EFO_0000319","MONDO_0024361","EFO_0003843","EFO_0000537","EFO_0000311","EFO_0000195","EFO_0003890","MONDO_0100096","MONDO_0000831","EFO_0000764","EFO_0008583","EFO_0007328","EFO_0004225","MONDO_0005148","HP_0002019","EFO_0005251"],"count":32},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 6 approved and 24 investigational indications."}
{"id":"CHEMBL230910","canonicalSmiles":"N[C@@H](CC(=O)N1CCCNC(=O)C1CC(F)(F)F)Cc1cc(F)c(F)cc1F","inchiKey":"RMDAPSXWBVPVOG-IAPIXIRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL230910","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07271"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2311030","canonicalSmiles":"CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CCC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O.CS(=O)(=O)O","inchiKey":"PBKVEOSEPXMKDN-LZHUFOCISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERGOLOID MESYLATES","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2364968","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alkergot","Circanol","Deapril","Deapril-st","Ergoloid mesylates","Gerimal","Hydergine","Hydergine lc","Hydrogenated ergot alkaloids"],"synonyms":["Co-dergocrine mesilate","Co-dergocrine mesylate","Codergocrine mesilate","Dihydroergotoxine mesilate","Dihydroergotoxine mesylate","Dihydroergotoxine methanesulfonate","Dihydrogenated ergot alkaloids","Ergoloid mesilates","Ergoloid mesylates","Hydrogenated ergot alkaloids"],"crossReferences":{"DailyMed":["ergoloid%20mesylates"],"DrugCentral":["5035"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000135312","ENSG00000178394","ENSG00000274286","ENSG00000184845","ENSG00000149295","ENSG00000069696","ENSG00000151577","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000169676","ENSG00000150594"],"count":13},"linkedDiseases":{"rows":["EFO_0004718","EFO_0000319","Orphanet_908"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for cardiovascular disease and has 1 investigational indication."}
{"id":"CHEMBL23194","canonicalSmiles":"NCCCNCCCCNCCCN","inchiKey":"PFNFFQXMRSDOHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4,9-diazadodecamethylenediamine","Actilip sp-91","Gerotine","Musculamine","NSC-268508","Neuridine","Spermine"],"crossReferences":{"PubChem":["11111791","11113818","124881425","124881427","26751991","90341642"],"Wikipedia":["Spermine"],"drugbank":["DB00127"],"chEBI":["15746"]},"childChemblIds":["CHEMBL1256357","CHEMBL1556584"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL23550","canonicalSmiles":"Nc1nc(O)c2ncn([C@@H]3C[C@H](CO)[C@H]3CO)c2n1","inchiKey":"GWFOVSGRNGAGDL-FSDSQADBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBUCAVIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-180194","Lobucavir","SQ 34,514","SQ-34514"],"crossReferences":{"drugbank":["DB12531"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2391146","canonicalSmiles":"CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)O)C(C)C","inchiKey":"JSQIKKVBLLHQSQ-AWJAZODESA-N","drugType":"Protein","blackBoxWarning":false,"name":"ANGIOTENSIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Angiotensin"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL241694","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"CHNXZKVNWQUJIB-CEGNMAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHISTERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ora-lutin","Pranone","Syngestrotabs","Trosinone"],"synonyms":["Anhydrohydroxyprogesterone","Ethisterone","NSC-9565","Pregneninolone"],"crossReferences":{"PubChem":["144204946","144205157","144212641","170466182","56422131","855561"],"Wikipedia":["Ethisterone"],"chEBI":["34749"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL251074","canonicalSmiles":"CC(=O)C[C@@H](c1ccccc1)c1c(O)c2ccccc2oc1=O","inchiKey":"PJVWKTKQMONHTI-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"S-Warfarin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["S-Warfarin"],"crossReferences":{"PubChem":["29217692"],"drugbank":["DB14055"],"chEBI":["87738"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258558","canonicalSmiles":"CC(C)(c1ccc(OCC2CO2)cc1)c1ccc(OCC2CO2)cc1","inchiKey":"LCFVJGUPQDGYKZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL258558","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144209339","144213632","17389141","26752169","26752170","26752171"],"drugbank":["DB14083"],"chEBI":["34578"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL282121","canonicalSmiles":"CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1","inchiKey":"VYVKHNNGDFVQGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBEVERINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Arluy","Mebeverine"],"crossReferences":{"Wikipedia":["Mebeverine"],"drugbank":["DB12554"]},"childChemblIds":["CHEMBL1446650"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for gastrointestinal disease and has 1 investigational indication."}
{"id":"CHEMBL29411","canonicalSmiles":"Cc1ccc(C(C)C)c(O)c1","inchiKey":"MGSRCZKZVOBKFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYMOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eftab","Gppe mthwsh tab","Listerine","Sotol","Tellodont","Tellora","Valda"],"synonyms":["3-hydroxy-p-cymene","Apiguard","FEMA NO. 3066","NSC-11215","NSC-47821","NSC-49142","P-cymen-3-ol","Thyme camphor","Thymol","Thymolum"],"crossReferences":{"PubChem":["144205166","144210676","170465504","29215297","47193695"],"Wikipedia":["Thymol"],"drugbank":["DB02513"],"chEBI":["27607"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3137345","drugType":"Antibody","blackBoxWarning":false,"name":"DULIGOTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Duligotumab","Duligotuzumab","MEHD-7945A","MEHD7945A","RG-7597","RG7597"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000065361"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","EFO_1001951"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3183704","drugType":"Small molecule","blackBoxWarning":false,"name":"FERROUS CHLORIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferrous chloride"],"crossReferences":{"PubChem":["144207395"],"chEBI":["30812"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL32479","canonicalSmiles":"Cc1nnc2n1-c1sc(Br)cc1C(c1ccccc1Cl)=NC2","inchiKey":"UMSGKTJDUHERQW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROTIZOLAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lendorm"],"synonyms":["Brotizolam","Lendormin","Mederantil","Nimbisan","Sintonal","WE 941","WE-941","WE-941-BS"],"crossReferences":{"PubChem":["144207150"],"Wikipedia":["Brotizolam"],"drugbank":["DB09017"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3301681","canonicalSmiles":"CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O","inchiKey":"ULLNJSBQMBKOJH-VIVFLBMVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBENOSIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["21401-BA","Hemocuron","Tribenoside"],"crossReferences":{"drugbank":["DB13227"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL332935","canonicalSmiles":"CC[N+](C)(CC)CCC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21","inchiKey":"ZDWVWKDAWBGPDN-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL332935","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112704","124882535","26756863"],"drugbank":["DB02166"],"chEBI":["51246"]},"childChemblIds":["CHEMBL345124"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL336908","canonicalSmiles":"O=C(O)C(=O)Nc1ccc(I)cc1C(=O)O","inchiKey":"SHSWHSQPJKMCPN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL336908","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02662"],"chEBI":["40326"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3527000","canonicalSmiles":"O=c1[nH]nc2c3c(cccc13)Oc1ccc(CN3CCC(O)CC3)cc1-2","inchiKey":"HAVFFEMDLROBGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"E-7016","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E 7016","E-7016","E7016","GPI-21016"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545110","canonicalSmiles":"CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1","inchiKey":"RHXHGRAEPCAFML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOCICLIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["LEE-011","LEE-011A","LEE011","LEE011A","Lee-011","NVP-LEE011","Ribociclib"],"crossReferences":{"DailyMed":["ribociclib%20succinate"],"drugbank":["DB11730"]},"childChemblIds":["CHEMBL4468983","CHEMBL3707266"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003869","MONDO_0044903","EFO_0001075","EFO_0003859","EFO_1001901","EFO_0000756","MONDO_0015686","MONDO_0007254","EFO_0000305","EFO_0003085","MONDO_0002158","EFO_1000044","EFO_0000182","EFO_1000251","EFO_0000196","EFO_0002499","EFO_0002626","MONDO_0002601","EFO_0000616","EFO_0005220","EFO_0000220","MONDO_0008170","EFO_0000313","EFO_1001968","EFO_0000621","EFO_0003060","MONDO_0008315","MONDO_0023206","EFO_0000311","EFO_1000026","EFO_1001100","EFO_0005701","EFO_0000574","EFO_0000519","EFO_0000181","EFO_0000569"],"count":37},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 34 investigational indications."}
{"id":"CHEMBL3545261","drugType":"Antibody","blackBoxWarning":false,"name":"BRONTICTUZUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brontictuzumab","OMP-52M51"],"linkedTargets":{"rows":["ENSG00000148400"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001480","EFO_0000311"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545272","drugType":"Small molecule","blackBoxWarning":false,"name":"LAS190792","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Las190792"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000133019"],"count":2},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545428","drugType":"Small molecule","blackBoxWarning":false,"name":"CHIAURANIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-2164","CS2164","Chiauranib","Cs-2164"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000178999","ENSG00000102755","ENSG00000037280"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008170","EFO_0000182","EFO_0000702","EFO_0005952"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3545985","canonicalSmiles":"C[C@@H](Cc1ccccc1)N(C)Cc1ccccc1","inchiKey":"YXKTVDFXDRQTKV-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENZPHETAMINE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Benzfetamine"],"crossReferences":{"DailyMed":["benzphetamine%20hydrochloride"],"drugbank":["DB00865"],"chEBI":["3044"]},"childChemblIds":["CHEMBL3544906"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000165646"],"count":2},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960 and is indicated for obesity."}
{"id":"CHEMBL3693786","canonicalSmiles":"O=C(CCCCCCNC(=O)c1cnc(N(c2ccccc2)c2ccccc2Cl)nc1)NO","inchiKey":"VLIUIBXPEDFJRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CITARINOSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACY-241","Citarinostat","HDAC-IN-2"],"crossReferences":{"drugbank":["DB15449"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3707229","drugType":"Antibody","blackBoxWarning":false,"name":"TEZEPELUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 157","MEDI19929","Tezepelumab"],"linkedTargets":{"rows":["ENSG00000145777"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","MONDO_0005271","MONDO_0004979","EFO_0000341","EFO_0000274","EFO_1002029"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3707268","canonicalSmiles":"C[C@]1(F)C[C@@](N)(C(=O)O)C1","inchiKey":"ILMJJAKSEOUEPX-IZLXSQMJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUCICLOVINE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fluciclovine"],"crossReferences":{"DailyMed":["fluciclovine%20f-18"]},"childChemblIds":["CHEMBL3707267"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 4 investigational indications."}
{"id":"CHEMBL3707382","drugType":"Enzyme","blackBoxWarning":true,"name":"VESTRONIDASE ALFA","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mepsevii"],"synonyms":["UX-003","UX003","Vestronidase alfa","Vestronidase alfa-vjbk"],"crossReferences":{"DailyMed":["vestronidase%20alfa-vjbk"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for mucopolysaccharidosis type 7 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL394429","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"GYOZYWVXFNDGLU-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THYMIDINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxythymidine Monophosphate","Thymidine Monophosphate","Thymidine-5'-Phosphate"],"crossReferences":{"Wikipedia":["Thymidine_monophosphate"],"drugbank":["DB01643"],"chEBI":["17013"]},"childChemblIds":["CHEMBL1627078"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989705","canonicalSmiles":"CCC(=O)[O-].O.[Na+]","inchiKey":"HOAUAOBUGFYWMK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PROPIONATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL500826","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sodium propionate"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989801","canonicalSmiles":"CC(=O)O.CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](COP(=O)(O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)[C@@H](C)CC)C(C)C","inchiKey":"AAYJNPGTWYJOET-VURLEEIPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FORIGERIMOD ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL3989409","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lupuzor"],"synonyms":["CEP-33457","Forigerimod acetate","IPP 201101","P-140","P140"],"linkedTargets":{"rows":["ENSG00000109971"],"count":1},"linkedDiseases":{"rows":["EFO_0002690"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3990043","drugType":"Gene","blackBoxWarning":false,"name":"DONAPERMINOGENE SELTOPLASMID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Donaperminogene seltoplasmid","Pck-hgfx7","VM202"],"description":"Gene drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4","canonicalSmiles":"CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23","inchiKey":"GSDSWSVVBLHKDQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OFLOXACIN","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exocin","Floxin","Floxin otic","Ocuflox","Ofloxacin","Tarivid","Tarivid 400","Tarivid i.v.","Visiren"],"synonyms":["DL-8280","HOE 280","HOE-280","J01MA01","NSC-727071","NSC-758178","Ofloxacin"],"crossReferences":{"DailyMed":["ofloxacin"],"PubChem":["11533038","124880995","124880996","144204254","170465035","174006255","174007433","26747609","26747610","50106760","56423109","85231170","90341488"],"Wikipedia":["Ofloxacin"],"drugbank":["DB01165"],"chEBI":["7731"]},"childChemblIds":["CHEMBL556371"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL413376","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)[O-])c3cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)[O-])c5cc(S(=O)(=O)[O-])cc(S(=O)(=O)[O-])c45)ccc3C)c2)c1.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]","inchiKey":"VAPNKLKDKUDFHK-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"SURAMIN HEXASODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL265502","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-205","BAYER-205","CI-1003","FOURNEAU 309","FOURNEAU-309","NF-060","NSC-758165","Nagananinum","Naphuride","Suramin hexasodium","Suramin sodium","Suraminum natricum"],"crossReferences":{"PubChem":["11112082","124881892","26747683","26753666","85231329"]},"linkedTargets":{"rows":["ENSG00000113578"],"count":1},"linkedDiseases":{"rows":["EFO_0003756","DOID_10113","EFO_0005044","HP_0001919","EFO_0000681","MONDO_0007254","MONDO_0008315","EFO_0003060","EFO_1001951","MONDO_0001187","EFO_0007294","EFO_0000673","EFO_0006544","EFO_0001378","EFO_1000796","EFO_1000158"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL415324","canonicalSmiles":"COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC","inchiKey":"NZHGWWWHIYHZNX-CSKARUKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRANILAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-341","NSC-758970","Rizaben","Tranilast"],"crossReferences":{"PubChem":["144204387","26719641","49645767","50103918","50103919","50103920","56422140","85231347","855567","90341124"],"Wikipedia":["Tranilast"],"drugbank":["DB07615"],"chEBI":["77572"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297321","canonicalSmiles":"CS(=O)(=O)OCCN(CCBr)c1c(C(=O)NCCOP(=O)(O)O)cc([N+](=O)[O-])cc1[N+](=O)[O-]","inchiKey":"GZSOKPMDWVRVMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PR-104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pr 104","Pr-104"],"crossReferences":{"drugbank":["DB05968"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297560","drugType":"Antibody","blackBoxWarning":false,"name":"GATIPOTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gatipotuzumab"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297581","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"TOMINERSEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS-443139 FREE ACID","Ionis httrx","Isis 443139","RG-6042 FREE ACID","RG6042","RG6042 FREE ACID","Rg6042","Ro7234292","Tominersen"],"linkedTargets":{"rows":["ENSG00000197386"],"count":1},"linkedDiseases":{"rows":["Orphanet_399"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297599","canonicalSmiles":"N[C@@H](CC(=O)Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1)C(=O)O","inchiKey":"PVPJTBAEAQVTPN-HRAQMCAYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPACYTARABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aspacytarabine","Astarabine","BST-236","Bst-236"],"childChemblIds":["CHEMBL4802250"],"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000062822","ENSG00000146143","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":11},"linkedDiseases":{"rows":["EFO_0000220","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297616","canonicalSmiles":"NC(=O)[C@](O)(CNc1nc(-c2cc(-c3ccon3)n(Cc3ccccc3F)n2)ncc1F)C(F)(F)F","inchiKey":"YWQFJNWMWZMXRW-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLINCIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IW-1701","IW1701","Iw-1701","Olinciguat"],"crossReferences":{"drugbank":["DB15238"]},"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["Orphanet_232","HP_0002571"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297764","drugType":"Unknown","blackBoxWarning":false,"name":"HETROMBOPAG OLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hetrombopag diolamine","Hetrombopag ethanolamine","Hetrombopag olamine","SHR-8735 OLAMINE","SHR8735 OLAMINE"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297766","drugType":"Unknown","blackBoxWarning":false,"name":"HYDROGEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hydrogen"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297832","drugType":"Antibody","blackBoxWarning":false,"name":"SUTIMLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIVV009","Bivv-009","Sutimlimab","TNT-009","TNT009"],"linkedTargets":{"rows":["ENSG00000182326"],"count":1},"linkedDiseases":{"rows":["EFO_0007160"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298018","drugType":"Unknown","blackBoxWarning":false,"name":"LY-3164530","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3164530","LY3164530","Ly 3164530","Ly-3164530","Ly3164530"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL45412","canonicalSmiles":"O=C(O)CC(=O)N[C@@H](CS)Cc1ccccc1","inchiKey":"REPVVNYZORKKPQ-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL45412","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01935"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL456341","canonicalSmiles":"CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C(=O)O)C[C@@H]21","inchiKey":"YCHYFHOSGQABSW-RTBURBONSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENABASUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ajulemic Acid","Ajulemic acid","CPL-7075","CPL7075","CT-3","HU-239","IP-751","JBT-101","Lenabasum","Resunab"],"crossReferences":{"Wikipedia":["Ajulemic_acid"],"drugbank":["DB12193"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594290","canonicalSmiles":"NCCNC1CCC(CC(=O)N[C@H]2Cc3cccc(C(=O)O)c3OB2O)CC1","inchiKey":"PFZUWUXKQPRWAL-PXCJXSSVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TANIBORBACTAM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taniborbactam","VNRX-5133","Vnrx-5133","Vnrx5133"],"childChemblIds":["CHEMBL4594291"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594353","canonicalSmiles":"Cc1nc2ccc(F)cc2n1-c1nc(N)c(F)c(Nc2ccc(C(F)(F)F)cc2)n1","inchiKey":"TWLWOOPCEXYVBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UNESBULIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bmi1 inhibitor ptc596","PTC 596","PTC-596","PTC596","Ptc-596","Ptc596","Unesbulin"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4594360","drugType":"Unknown","blackBoxWarning":false,"name":"TRK-950","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Monoclonal antibody trk-950","TRK-950","Trk-950"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594496","drugType":"Unknown","blackBoxWarning":false,"name":"SEA-BCMA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-bcma antibody sea-bcma","Sea-bcma"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594570","drugType":"Unknown","blackBoxWarning":false,"name":"LHC-165","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LHC-165","LHC165","Lhc-165","Lhc165"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594605","drugType":"Unknown","blackBoxWarning":false,"name":"OMFILOCTOCOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Omfiloctocog alfa","SCT-800","SCT800","Sct800"],"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650361","canonicalSmiles":"C[C@@H](N)COc1ccc(-c2cnc3ccc(N[C@H](C)c4cccc(F)c4)nn23)cc1.O=C(O)CCCCC(=O)O","inchiKey":"DORJQZDOULKINH-QNBGGDODSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALETRECTINIB ADIPATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4650989","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-6051B","Ds-6051b","Taletrectinib adipate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650374","drugType":"Unknown","blackBoxWarning":false,"name":"APG-2575","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APG-2575","APG2575","Apg-2575","Apg2575","Lisaftoclax"],"linkedTargets":{"rows":["ENSG00000171791"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000095","EFO_0004289","MONDO_0007254","EFO_0000222","EFO_1001875","EFO_0001378","EFO_0000311"],"count":8},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4650461","drugType":"Unknown","blackBoxWarning":false,"name":"CSL-324","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anumigilimab","CSL-324","CSL324","Csl-324","Csl324"],"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650509","drugType":"Antibody","blackBoxWarning":false,"name":"MIBAVADEMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mibavademab","REGN-4461","REGN4461","Regn4461"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650520","drugType":"Antibody","blackBoxWarning":false,"name":"LEMZOPARLIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lemzoparlimab","TJ-011133","TJ011133","Tj011133"],"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL46780","canonicalSmiles":"Cn1c(Cc2ccc(C(=N)N)cc2)nc2cc(NS(=O)(=O)c3ccccc3)ccc21","inchiKey":"MEUAVGJWGDPTLF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL506110","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OCOC(=O)[C@@H]1N2C(=O)C[C@H]2S(=O)(=O)C1(C)C","inchiKey":"OPYGFNJSCUDTBT-PMLPCWDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULTAMICILLIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Unasyn"],"synonyms":["Bacimex","CP-49,952","CP-49952","Sultamicillin","Sultamicillin tosilate","Sultamicillin tosylate","Unacid","VD-1827"],"crossReferences":{"Wikipedia":["Sultamicillin"],"drugbank":["DB12127"],"chEBI":["51770"]},"childChemblIds":["CHEMBL3183856"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL510095","canonicalSmiles":"CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C[C@]12C","inchiKey":"PWAOOJDMFUQOKB-WCZZMFLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GINSENOSIDE RE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chikusetsusaponin ivc","Ginsenoside b2","Ginsenoside re","NSC-308877","Panaxoside re","Sanchinoside re"],"crossReferences":{"drugbank":["DB14815"],"chEBI":["77148"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL511142","canonicalSmiles":"CO[C@@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"RMRJXGBAOAMLHD-CTAPUXPBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPRENORPHINE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bupeaze","Buplast","Butec","Butrans","Hapoctasin","Panitaz","Prenotrix","Reletrans","Sevodyne","Sublocade","Temgesic","Tephine","Transtec"],"synonyms":["ALKS-5461 COMPONENT BUPRENORPHINE","Brixadi","Buprenorphin","Buprenorphine","Suboxone"],"crossReferences":{"DailyMed":["buprenorphine","buprenorphine%20hydrochloride"]},"childChemblIds":["CHEMBL2368861"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0004240","EFO_0002610","MONDO_0002009","Orphanet_232","MONDO_0002050","HP_0003419","EFO_0004701","EFO_0003047","EFO_0005799","HP_0008419","EFO_1001250","EFO_0005762","HP_0012532","EFO_0005612","EFO_0010072","EFO_0001358","HP_0003418","EFO_0010702","EFO_0010445","EFO_0003843","EFO_0000311","EFO_1001412","EFO_0004220","EFO_0003890","MONDO_0002491","EFO_0005800","EFO_0000764","EFO_0005611","EFO_0004270","MONDO_0005178","EFO_0000181"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 6 approved and 21 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL521078","canonicalSmiles":"CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@H]1[C@@H]2N1C","inchiKey":"HRHKSTOGXBBQCB-VFWICMBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PORFIROMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-methylmitomycin c","NSC-56410","Porfiromycin","U-14,743","U-14743"],"crossReferences":{"drugbank":["DB06478"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL561318","canonicalSmiles":"O=C(CN1C[C@H](O)[C@@H](NC(=O)c2ccc(Cl)s2)C1)Nc1ccc(-n2ccccc2=O)cc1F","inchiKey":"ARAVOODWJJJNBY-IRXDYDNUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL561318","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07875"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL604710","canonicalSmiles":"O=C(CC(c1ccccc1)c1ccccc1)N1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"VCPMZDWBEWTGNW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Z160","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-6721","MK6721","NMED-160","NP-118809","Z-160","Z160"],"crossReferences":{"drugbank":["DB12743"]},"linkedTargets":{"rows":["ENSG00000148408"],"count":1},"linkedDiseases":{"rows":["MONDO_0041052","MONDO_0002959"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL63055","canonicalSmiles":"O=C(O)CN1C(=O)c2cccc3cccc(c23)C1=O","inchiKey":"GCUCIFQCGJIRNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALRESTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AY-22284","Alrestatin","NSC-299132"],"crossReferences":{"PubChem":["11113527","170466470","26751737"],"drugbank":["DB02020"]},"childChemblIds":["CHEMBL2106598"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL633","canonicalSmiles":"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1","inchiKey":"IYIKLHRQXLHMJQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMIODARONE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cordarone"],"synonyms":["Amiodarone","Cordarone","L-3428","Pacerone","SKF 33134-A"],"crossReferences":{"DailyMed":["amiodarone%20hydrochloride"],"PubChem":["104171110","11110784","11110785","124879287","144203634","170464920","26751596","26751597","50100172","90341282"],"TG-GATEs":["33"],"Wikipedia":["Amiodarone"],"drugbank":["DB01118"],"chEBI":["2663"]},"childChemblIds":["CHEMBL1083993"],"linkedTargets":{"rows":["ENSG00000055118"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0000318","EFO_0001645","EFO_0004278","EFO_0005529","EFO_0000373","Orphanet_85443","EFO_0003911","MONDO_0100096","EFO_0004287","EFO_0005306","EFO_0003144","HP_0004308","HP_0004755","EFO_0000612","EFO_0007243","EFO_0009492"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved and 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL658","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1(COC)CCN(CCc2cccs2)CC1","inchiKey":"GGCSSNBKKAUURC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SUFENTANIL","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["IDS-NS-001","R 30,730","R-30730","Sufentanil","Sufentanyl"],"crossReferences":{"DailyMed":["sufentanil%20citrate"],"Wikipedia":["Sufentanil"],"drugbank":["DB00708"],"chEBI":["9316"]},"childChemblIds":["CHEMBL1201163","CHEMBL4747678"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0000546","EFO_1001139","EFO_1001219","HP_0012532","EFO_0005323","EFO_1000652","EFO_0000432","EFO_0009267","EFO_0000266","HP_0003418","EFO_0003843","EFO_0002950"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for pain and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL757","canonicalSmiles":"C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O","inchiKey":"NPAGDVCDWIYMMC-IZPLOLCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NANDROLONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deca-Durabolin","Durabolin","NSC-3351","Nandrolone","Nandrolone ciii"],"crossReferences":{"PubChem":["144206718","144206750","144208410","170466348","29215354","85148374"],"Wikipedia":["Nandrolone"],"drugbank":["DB13169"],"chEBI":["7466"]},"childChemblIds":["CHEMBL3337497"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL76688","canonicalSmiles":"CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1","inchiKey":"BTGNGJJLZOIYID-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIVELESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-544349","LY544349","ONO-5046","Sivelestat"],"crossReferences":{"Wikipedia":["Sivelestat"],"drugbank":["DB12863"]},"childChemblIds":["CHEMBL3182314","CHEMBL2107493"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL816","canonicalSmiles":"NCCN","inchiKey":"PIICEJLVQHRZGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYLENEDIAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Edamine","Ethylene diamine","Ethylenediamine"],"crossReferences":{"PubChem":["144204696","144208400","17389605"],"Wikipedia":["Ethylenediamine"],"drugbank":["DB14189"],"chEBI":["30347"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL86","canonicalSmiles":"CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC","inchiKey":"TTWJBBZEZQICBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METOCLOPRAMIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Clopra","Clopra-\"Yellow\"","Elieten","Maxolon","Methoxyclopramide","Metoclopramide","Reglan","Terperan"],"crossReferences":{"DailyMed":["metoclopramide%20hydrochloride"],"PubChem":["11111421","11111422","144203739","170464848","26751627","90341551"],"Wikipedia":["Metoclopramide"],"drugbank":["DB01233"],"chEBI":["107736"]},"childChemblIds":["CHEMBL1200940","CHEMBL1256771"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000164270","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["HP_0002239","HP_0002321","EFO_0005252","EFO_1000948","EFO_1002048","MONDO_0004565","HP_0002018","EFO_0002950","EFO_0003913","EFO_0003948","MONDO_0005277","EFO_1000645","HP_0002017","HP_0002013","EFO_0003917","EFO_0000198","EFO_0000616","EFO_0006911","HP_0002039","EFO_1000949","EFO_0003843","HP_0002315","EFO_1000971","MONDO_0008315","EFO_0000311","MONDO_0100431","EFO_0000546","HP_0100806","EFO_1001463","EFO_0010282","Orphanet_230","EFO_0000764","EFO_0004888","EFO_0008583","EFO_0000612","EFO_0005611","HP_0001943","MONDO_0005475"],"count":38},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 8 approved and 19 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL929","canonicalSmiles":"CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1.CS(=O)(=O)O","inchiKey":"MEPNHSOMXMALDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELAVIRDINE MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL593","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rescriptor"],"synonyms":["Delavirdine mesilate","Delavirdine mesylate","Delavirdine methanesulfonate","Rescriptor","U-90152S","U-90152T"],"crossReferences":{"chEBI":["4379"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication."}
